ipamorelin human study growth hormone secretion PDF) Ipamorelin, the first selective secretagogue ipamorelin human study growth hormone

Based on available Phase 2 data, both agents share a side-effect profile broadly consistent with other medicines acting on metabolic hormone pathways, though the triple-agonist mechanism of retatrutide introduces some additional considerations

Key Features Sterile, non-pyrogenic diluent for injection Contains 0.9% benzyl alcohol preservative Multi-dose vial for repeated use 30 mL volume Designed for dilution or reconstitution of injectable medications Suitable for professional medical use Common Uses Reconstituting medications Diluting injectable drugs Clinical and healthcare facility applications **Note Sterile and latex free Store between 20 and 25 degree

This animal safety profile is encouraging, but animal safety data does not establish that a compound is safe in humans

10.1016/S0028-3908(02)00155-7 106